Lilly provides update on 2024 revenue guidance, announces 2025 …
Jan 14, 2025 · For Q4 2024, Lilly now expects worldwide revenue to be approximately $13.5 billion, representing growth of 45% compared to Q4 2023. This includes approximately $3.5 …
Lilly confirms date and conference call for fourth-quarter 2024 ...
INDIANAPOLIS, Jan. 23, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter 2024 financial results and 2025 financial guidance on Feb. 6, 2025.Lilly will …
Quarterly Results | Eli Lilly and Company
Stock Info Webcasts & Presentations. Financials. Individual Investors ... Lilly Reports Fourth-Quarter 2014 Results 1 MB. Financial Workbook (.xls) 476 KB. Financial Workbook (.xlsx) 222 …
Lilly confirms date and conference call for fourth-quarter 2024 ...
6 days ago · INDIANAPOLIS, Jan. 23, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter 2024 financial results and 2025 financial guidance on Feb. 6, …
Eli Lilly stock tumbles after new forecasts show weight-loss drug …
Jan 14, 2025 · Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations. …
Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion …
Jan 14, 2025 · Eli Lilly expects fourth-quarter 2024 revenue of approximately $13.5 billion, representing a 45% year-over-year growth compared to the consensus of $13.97 billion. The …
Lilly Cuts Q4 Revenue View Below Market, Lifts FY24 Outlook; …
Jan 14, 2025 · (RTTNews) - Drug major Eli Lilly and Co. (LLY) on Tuesday trimmed its fourth-quarter revenue view below the Street estimates, but raised forecast for fiscal 2024 revenues. …
Eli Lilly stock gains as Q4 beats on obesity drugs (NYSE:LLY)
Feb 6, 2024 · Eli Lilly (NYSE: LLY) traded higher pre-market Tuesday after the pharma giant posted better-than-expected financials for Q4 2024 as sales from its new diabetes and weight …
Should You Buy the Dip in Eli Lilly Stock Right Now?
Jan 19, 2025 · Shares of pharmaceutical stock Eli Lilly are cratering after the company lowered its sales guidance for Q4. 2024 was an interesting year for pharmaceutical powerhouse Eli Lilly ( …
Eli Lilly: Market Overreacted (NYSE:LLY) - Seeking Alpha
Jan 21, 2025 · On January 14th, Eli Lilly (NYSE:LLY) released updated revenue guidance for Q4 FY24, with a $400 million reduction from the previously issued forecast.The stock dropped …
- Some results have been removed